Rounding out the other four largest financing rounds in 2024 are proteomics company Alamar Biosciences' $128 million Series C ...

Biomy has developed its DeepPathFinder digital pathology platform to analyze images to classify cell and tissue types in specific regions.

The chemiluminescence-based immunoassay is used for the direct quantitative measurement of free testosterone in serum or plasma, with results in 48 minutes.

NEW YORK – After two years of decline in 2022 and 2023, the 360Dx Top 30 rebounded in 2024, rising 4 percent year over year.

The funding will be used to move the ARGO-HT research platform into an FDA-cleared system to support the development of diagnostic tests.

Physicians Toxicology Laboratory had been accused of encouraging client healthcare practices to order drug tests for all patients regardless of medical need.

Last week, readers were most interested in a story about the progress made by test developers toward commercializing rapid tests for sepsis.

Labcorp will take over the daily operations of three Inspira Health hospital labs, and it will serve as the primary lab for Inspira's physician network.

The expanded clearance adds the Ventana DP 600 slide scanner to Roche's previous whole-slide imaging system that was cleared last year.

Innovaccer on Thursday announced separately that it has closed a $275 million Series F funding round that includes participation from Danaher Ventures and others.